{"id":"https://openalex.org/W4240769816","doi":"https://doi.org/10.1016/j.jval.2019.09.774","title":"PCV49 COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PORTUGUESE PATIENTS","display_name":"PCV49 COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PORTUGUESE PATIENTS","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W4240769816","doi":"https://doi.org/10.1016/j.jval.2019.09.774"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2019.09.774","doi":"https://doi.org/10.1016/j.jval.2019.09.774","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.774","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301519331523/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.valueinhealthjournal.com/article/S1098301519331523/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008963665","display_name":"F. de Andr\u00e9s-Nogales","orcid":"https://orcid.org/0000-0002-9124-7150","observed_orcids":["https://orcid.org/0000-0002-9124-7150"]},"institutions":[{"id":"https://openalex.org/I4210165298","display_name":"Pharmacoeconomics and Health Outcomes Research Iberia (Spain)","ror":"https://ror.org/05sb05859","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210165298"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"F. de Andr\u00e9s-Nogales","raw_affiliation_strings":["Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarcon, M, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarcon, M, Spain","institution_ids":["https://openalex.org/I4210165298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049548428","display_name":"P.R. Gay-Pobes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165298","display_name":"Pharmacoeconomics and Health Outcomes Research Iberia (Spain)","ror":"https://ror.org/05sb05859","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210165298"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"P.R. Gay-Pobes","raw_affiliation_strings":["Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarc\u00f3n, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarc\u00f3n, Spain","institution_ids":["https://openalex.org/I4210165298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069666194","display_name":"Merida In\u00e8s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254080","display_name":"Pfizer (Portugal)","ror":"https://ror.org/01ctjz153","country_code":"PT","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4405254080"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"M. In\u00eas","raw_affiliation_strings":["Laborat\u00f3rios Pfizer, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laborat\u00f3rios Pfizer, Lisbon, Portugal","institution_ids":["https://openalex.org/I4405254080"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017452547","display_name":"C. Polanco S\u00e1nchez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Polanco S\u00e1nchez","raw_affiliation_strings":["Bristol-Myers Squibb, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109750131","display_name":"David Nilson Gondim Alves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254633","display_name":"Bristol-Myers Squibb (Portugal)","ror":"https://ror.org/0223rpe14","country_code":"PT","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4405254633"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"D. Alves","raw_affiliation_strings":["Bristol-Myers Squibb, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Lisbon, Portugal","institution_ids":["https://openalex.org/I4405254633"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069146288","display_name":"Itziar Oyag\u00fcez","orcid":"https://orcid.org/0000-0002-3047-6152","observed_orcids":["https://orcid.org/0000-0002-3047-6152"]},"institutions":[{"id":"https://openalex.org/I4210165298","display_name":"Pharmacoeconomics and Health Outcomes Research Iberia (Spain)","ror":"https://ror.org/05sb05859","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210165298"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I. Oyag\u00fcez","raw_affiliation_strings":["Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarc\u00f3n, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoeconomics & Outcomes Research Iberia (PORIB), Pozuelo de Alarc\u00f3n, Spain","institution_ids":["https://openalex.org/I4210165298"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2850,"currency":"USD","value_usd":2850},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":"S549","last_page":"S550"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.01860000006854534,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.9890000224113464},{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":1.0},{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9679999947547913},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8289999961853027},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.8709999918937683},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.7689999938011169},{"id":"https://openalex.org/keywords/life-years-gained","display_name":"life-years gained","score":0.7160000205039978},{"id":"https://openalex.org/keywords/incremental-cost-utility-ratio","display_name":"incremental cost-utility ratio","score":0.7400000095367432},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.6480000019073486},{"id":"https://openalex.org/keywords/indirect-treatment-comparison","display_name":"indirect treatment comparison","score":0.6819999814033508},{"id":"https://openalex.org/keywords/aristotle-trial","display_name":"ARISTOTLE trial","score":0.7950000166893005},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.42800000309944153}],"concepts":[{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.9772840738296509},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.9388163089752197},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9290473461151123},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.5733730792999268},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4163852334022522},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.4118432104587555},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4013557434082031},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.23745623230934143},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.052605628967285156},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2019.09.774","doi":"https://doi.org/10.1016/j.jval.2019.09.774","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.774","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301519331523/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2019.09.774","doi":"https://doi.org/10.1016/j.jval.2019.09.774","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2019.09.774","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301519331523/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4240769816.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2906022760","https://openalex.org/W1852447234","https://openalex.org/W2982664911","https://openalex.org/W4230204526","https://openalex.org/W1889708260","https://openalex.org/W2399654950","https://openalex.org/W2906139708","https://openalex.org/W2232057927","https://openalex.org/W2177624060","https://openalex.org/W6920814789"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-05-12T00:00:00"}